al., demonstrated that miR-195-5p is downregulated in cervical cancer serum and tissue samples, and can increase cancer cell invasiveness by regulating the target gene cyclin D1, which can be used as its therapeutic target [28]. This evidence concerns the gene CCND1 and cancer.